160 related articles for article (PubMed ID: 31037601)
1. Correction to: Sarecycline: First Global Approval.
Deeks ED
Drugs; 2019 May; 79(7):795. PubMed ID: 31037601
[TBL] [Abstract][Full Text] [Related]
2. Correction to: Polatuzumab Vedotin: First Global Approval.
Deeks ED
Drugs; 2019 Nov; 79(16):1829. PubMed ID: 31617142
[TBL] [Abstract][Full Text] [Related]
3. Correction to: GP2015: An Etanercept Biosimilar.
Deeks ED
BioDrugs; 2018 Oct; 32(5):525. PubMed ID: 30069733
[TBL] [Abstract][Full Text] [Related]
4. Correction to: Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Review in HIV-1 Infection.
Deeks ED
Drugs; 2019 Apr; 79(6):687. PubMed ID: 30903610
[TBL] [Abstract][Full Text] [Related]
5. Correction to: Revefenacin: First Global Approval.
Heo YA
Drugs; 2019 Apr; 79(6):689. PubMed ID: 30927162
[TBL] [Abstract][Full Text] [Related]
6. Correction to: Migalastat: A Review in Fabry Disease.
McCafferty EH; Scott LJ
Drugs; 2019 Aug; 79(12):1363. PubMed ID: 31292908
[TBL] [Abstract][Full Text] [Related]
7. Correction to: Ubrogepant: First Approval.
Scott LJ
Drugs; 2020 Apr; 80(5):523. PubMed ID: 32166599
[TBL] [Abstract][Full Text] [Related]
8. Correction to: Triheptanoin: First Approval.
Shirley M
Drugs; 2020 Nov; 80(17):1873. PubMed ID: 33090331
[TBL] [Abstract][Full Text] [Related]
9. Correction to: Bimatoprost Implant: First Approval.
Shirley M
Drugs Aging; 2020 Jul; 37(7):549. PubMed ID: 32557177
[TBL] [Abstract][Full Text] [Related]
10. Correction to: Nonacog Beta Pegol: A Review in Haemophilia B.
Syed YY
Drugs; 2018 Jul; 78(11):1169. PubMed ID: 30003467
[TBL] [Abstract][Full Text] [Related]
11. Correction to: OnabotulinumtoxinA: A Review in the Prevention of Chronic Migraine.
Frampton JE; Silberstein S
Drugs; 2018 Apr; 78(6):715. PubMed ID: 29679281
[TBL] [Abstract][Full Text] [Related]
12. Correction to: Lonoctocog Alfa: A Review in Haemophilia A.
Al-Salama ZT; Scott LJ
Drugs; 2018 Mar; 78(4):521. PubMed ID: 29500556
[TBL] [Abstract][Full Text] [Related]
13. Correction to: Tocilizumab: A Review in Rheumatoid Arthritis.
Scott LJ
Drugs; 2018 Feb; 78(2):285. PubMed ID: 29260457
[TBL] [Abstract][Full Text] [Related]
14. Correction to: Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features.
Lyseng-Williamson KA
Clin Drug Investig; 2019 Oct; 39(10):1019. PubMed ID: 31512163
[TBL] [Abstract][Full Text] [Related]
15. Correction to: Cladribine Tablets: A Review in Relapsing MS.
Deeks ED
CNS Drugs; 2019 Feb; 33(2):193. PubMed ID: 30697664
[TBL] [Abstract][Full Text] [Related]
16. Correction to: Tapentadol Prolonged Release: A Review in Pain Management.
Deeks ED
Drugs; 2019 Apr; 79(5):589. PubMed ID: 30895475
[TBL] [Abstract][Full Text] [Related]
17. Correction to: Damoctocog Alfa Pegol: A Review in Haemophilia A.
Paik J; Deeks ED
Drugs; 2019 Sep; 79(13):1495. PubMed ID: 31444769
[TBL] [Abstract][Full Text] [Related]
18. Correction to: Trifluridine/Tipiracil: A Review in Metastatic Gastric Cancer.
Kang C; Dhillon S; Deeks ED
Drugs; 2019 Oct; 79(15):1727. PubMed ID: 31535330
[TBL] [Abstract][Full Text] [Related]
19. Correction to: Eculizumab: A Review in Neuromyelitis Optica Spectrum Disorder.
Frampton JE
Drugs; 2020 May; 80(7):729. PubMed ID: 32319075
[TBL] [Abstract][Full Text] [Related]
20. Correction to: How the 2018 US Physical Activity Guidelines are a Call to Promote and Better Understand Acute Physical Activity for Cognitive Function Gains.
Chang YK; Erickson KI; Stamatakis E; Hung TM
Sports Med; 2020 Mar; 50(3):639. PubMed ID: 31686384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
